Terms: = Thyroid cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Treatment
5670 results:
1. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
Zhao H; Kang W; Guan J; Wang Y
Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
[TBL] [Abstract] [Full Text] [Related]
2. Trends and projections of the global burden of thyroid cancer from 1990 to 2030.
Hu S; Wu X; Jiang H
J Glob Health; 2024 May; 14():04084. PubMed ID: 38751316
[TBL] [Abstract] [Full Text] [Related]
3. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
4. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
[TBL] [Abstract] [Full Text] [Related]
5. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
6. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
[TBL] [Abstract] [Full Text] [Related]
7. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
8. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of fibrin sealant application in patients undergoing thyroidectomy: a systematic review and meta-analysis.
Zheng X; Wang F; Su YC; Xu CY; Wang MZ
BMC Surg; 2024 Apr; 24(1):122. PubMed ID: 38658932
[TBL] [Abstract] [Full Text] [Related]
11. Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
Fugazzola L; Deandrea M; Borgato S; Dell'Acqua M; Retta F; Mormile A; Carzaniga C; Gazzano G; Pogliaghi G; Muzza M; Persani L
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657647
[TBL] [Abstract] [Full Text] [Related]
12. PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
Kuboki Y; Koyama T; Matsubara N; Naito Y; Kondo S; Harano K; Yonemori K; Yoh K; Gu Y; Mita T; Chen X; Ueda E; Yamamoto N; Doi T; Shimizu T
Cancer Med; 2024 Apr; 13(8):e6980. PubMed ID: 38651187
[TBL] [Abstract] [Full Text] [Related]
13. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
[TBL] [Abstract] [Full Text] [Related]
14. Prevalence and impact of endocrine disorders in advanced metastatic cancer patients undergoing cancer-directed therapy: A prospective observational study.
Karna G; Sehrawat A; Karna S; Kant R; Sundriyal D; Karn S; Jha D
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2011. PubMed ID: 38644759
[TBL] [Abstract] [Full Text] [Related]
15. Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.
Colombo C; Ceruti D; Succi M; De Leo S; Trevisan M; Moneta C; Fugazzola L
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642580
[TBL] [Abstract] [Full Text] [Related]
16. thyroid nodule rupture after radiofrequency ablation: case report and literature review.
Ferraro T; Sajid S; Hodak SP; Baldwin CK
Front Endocrinol (Lausanne); 2024; 15():1355383. PubMed ID: 38628591
[TBL] [Abstract] [Full Text] [Related]
17. Long-Term Follow-up of Patients With Autonomous thyroid Nodules Treated With Radioiodine.
Moroto D; Torquato-Vieira ICO; Fiorin LB; Camacho CP; Castiglioni MLV; Maciel RMB; Furlanetto RP; Matsumura LK; Janovsky CCPS; Lindsey SC; Martins JRM
Clin Nucl Med; 2024 Jun; 49(6):529-535. PubMed ID: 38619976
[TBL] [Abstract] [Full Text] [Related]
18. Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis.
Yang P; Shen G; Zhang H; Zhang C; Li J; Zhao F; Li Z; Liu Z; Wang M; Zhao J; Zhao Y
Int Immunopharmacol; 2024 May; 133():111961. PubMed ID: 38608442
[TBL] [Abstract] [Full Text] [Related]
19. Factors associated with non-completion of palliative radiotherapy for spinal metastasis in patients with terminal cancer: a retrospective study.
Tokiya R; Nakanishi K; Okawaki M; Yamamoto A; Yamamoto Y; Saisho S; Fukuda Y; Nishie H; Teramoto S; Miyaji Y
Ann Palliat Med; 2024 Mar; 13(2):249-259. PubMed ID: 38584473
[TBL] [Abstract] [Full Text] [Related]
20. Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates Breast Tumor Metastasis.
Xu J; Zhou Y; He S; Wang Y; Ma J; Li C; Liu Z; Zhou X
Drug Metab Dispos; 2024 Apr; 52(5):408-421. PubMed ID: 38575184
[TBL] [Abstract] [Full Text] [Related]
[Next]
